OSSEOTITE® CERTAIN® IOSS585Recalls & reported problems
ZimVie US Corp LLC · OSSEOTITE® CERTAIN® IMPLANT 5 X 8.5MM · Class 2 · Implant
All models of OSSEOTITE CERTAIN (74)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 7
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00844868007197), received between Dec 18, 2019 and Aug 16, 2026 — classified as 7 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem7
Patient problems
- Unspecified Infection5
- Pain4
- Inflammation2
- Osteolysis2
- No Clinical Signs, Symptoms or Conditions1
- No Information1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
InjuryAug 16, 2026Adverse Event Without Identified Device or Use Problem
Doctor reported that implant was removed due to Peri-implantitis with complete loss of integration. Tooth site 26.
Patient problems: Osteolysis; Unspecified Infection
MAUDE report 50266169 ↗InjuryMar 3, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED AN INFECTION AT TOOTH SITES 26-27. AFTER 3 WEEKS OF IMPLANTATION, IT WAS REPORTED INFECTION. IT WAS TREATED WITH ANTIBIOTICS ON (B)(6) 2025 AND, A WEEK LATER ON (B)(6) 2025, IT WAS DECIDED TO REMOVE THE IMPLANTS. ABSCESS, INFLAMMATION AND PAIN WERE REPORTED AS A RESULT OF THE EVENT. THIS REPORT REFERS TO (B)(6) INFECTION.
Patient problems: Inflammation; Pain; Unspecified Infection
MAUDE report 21503528 ↗InjuryMar 3, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED AN INFECTION AT TOOTH SITES 26-27. AFTER 3 WEEKS OF IMPLANTATION, IT WAS REPORTED INFECTION. IT WAS TREATED WITH ANTIBIOTICS ON (B)(6) 2025 AND, A WEEK LATER ON (B)(6) 2025, IT WAS DECIDED TO REMOVE THE IMPLANTS. ABSCESS, INFLAMMATION AND PAIN WERE REPORTED AS A RESULT OF THE EVENT. THIS REPORT REFERS TO (B)(6) INFECTION.
Patient problems: Inflammation; Pain; Unspecified Infection
MAUDE report 21503291 ↗InjuryMay 8, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
NO FURTHER EVENT INFORMATION IS AVAILABLE AT THE TIME OF THIS REPORT.
Patient problems: Pain
MAUDE report 19270920 ↗InjuryApr 12, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE DOCTOR REPORTED THAT THE DENTAL IMPLANT LOCATED IN POSITION NUMBER #19 FAILED DUE TO PERI-IMPLANTITIS. THE SYMPTOM AS A RESULT OF THE EVENT IS PAIN.
Patient problems: Osteolysis; Pain; Unspecified Infection
MAUDE report 16725537 ↗InjurySep 10, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THE IMPLANT AT TOOTH SITE # 14 LACKED PRIMARY STABILITY AND WAS REMOVED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12452363 ↗InjuryDec 18, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
NO FURTHER EVENT INFORMATION IS AVAILABLE AT THE TIME OF THIS REPORT.
Patient problems: No Information; Unspecified Infection
MAUDE report 9487266 ↗
Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices
- Straumann® Dental Implant System Roxolid® SLA Impl. SLA Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM43,616 reports
- STRAUMANN BONE LEVEL TAPERED IMPLANT SLActive Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM40,404 reports
- Straumann® Dental Implant System Roxolid® SLA Impl. SLA Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM27,400 reports
- STRAUMANN BONE LEVEL TAPERED IMPLANT SLActive Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM25,621 reports
- STRAUMANN BONE LEVEL TAPERED IMPLANT SLA Titanium BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM25,298 reports
- Straumann® Dental Implant System Roxolid® SLA Impl. SLA Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM23,448 reports
- STRAUMANN BONE LEVEL TAPERED IMPLANT SLActive Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM22,320 reports
- STRAUMANN BONE LEVEL TAPERED IMPLANT SLActive Roxolid BLInstitut Straumann AG · IMPLANT, ENDOSSEOUS, ROOT-FORM22,267 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page